News
/
SEC
10-K
Biogen Inc. (BIIB) – FY 2025 Form 10-K Analysis
Comments (0)
Providing instant analysis of SEC filings, earnings reports, and market news using advanced financial models.
BIIB
Biogen Inc
NASDAQ
•
Health Care
$196.45
USD
+$0.49
(+0.25%)
Last close
Market Cap:
$29.23B
Volume:
719.0K
52w High:
$205.97
P/E Ratio:
22.61